Antares Pharma Inc  

(Public, NASDAQ:ATRS)   Watch this stock  
Find more results for ATRS
2.11
0.00 (0.00%)
Jun 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 1.82 - 3.04
Open     -
Vol / Avg. 0.00/939,424.00
Mkt cap 320.19M
P/E     -
Div/yield     -
EPS -0.25
Shares 131.75M
Beta 0.65
Inst. own 36%
Aug 5, 2015
Q2 2015 Antares Pharma Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jun 23, 2015
Antares Pharma Inc at JMP Securities Life Sciences Conference
Jun 4, 2015
Antares Pharma Inc at Jefferies Global Healthcare Conference
May 28, 2015
Antares Pharma Inc Annual Shareholders Meeting
May 13, 2015
Antares Pharma Inc at Bank of America Merrill Lynch Health Care Conference
May 11, 2015
Q1 2015 Antares Pharma Inc Earnings Release
May 11, 2015
Q1 2015 Antares Pharma Inc Earnings Call
May 6, 2015
Antares Pharma Inc at Deutsche Bank Health Care Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -81.31% -132.64%
Operating margin -80.76% -132.49%
EBITD margin - -127.88%
Return on average assets -42.73% -44.58%
Return on average equity -71.32% -62.82%
Employees 93 -
CDP Score - -

Address

SUITE 300, 100 PRINCETON SOUTH
EWING, NJ 8628
United States - Map
+1-609-3593020 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical Company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures for itself and with partners, pressure-assisted injectors, with and without needles, which allow patients to self-inject drugs. It has developed variations of the needle-free injector by adding a small shielded needle to a pre-filled, single-use disposable injector, called the Vibex pressure assisted auto injection system. This system is an alternative to the needle-free system for use with injectable drugs in unit dose containers and is suitable for branded and generic injectables. It has also developed a disposable multi-dose pen injector for use with standard cartridges.

Officers and directors

Leonard S. Jacob M.D., Ph.D. Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Eamonn P. Hobbs President, Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
James E. Fickenscher Chief Financial Officer, Senior Vice President
Age: 51
Bio & Compensation  - Reuters
Robert F. Apple CPA, Chief Operating Officer, Executive Vice President, President - Parenteral Products Division
Age: 48
Bio & Compensation  - Reuters
Jennifer Evans Stacey Esq. Senior Vice President, General Counsel, Human Resources and Secretary
Age: 50
Bio & Compensation  - Reuters
Thomas J. Garrity Independent Director
Age: 66
Bio & Compensation  - Reuters
Jacques Gonella Ph.D. Independent Director
Age: 73
Bio & Compensation  - Reuters
Anton G. Gueth Independent Director
Age: 58
Bio & Compensation  - Reuters
Robert P. Roche Jr. Independent Director
Age: 59
Bio & Compensation  - Reuters
Marvin Samson Independent Director
Age: 67
Bio & Compensation  - Reuters